In addition to controlling the expression of many genes involved in lipid metabolism, and insulin sensitization, it has been found that PPARγ functions as a tumor suppressor in a variety of malignancies such as breast cancer, colon cancer, liposarcoma, ovarian cancer, and prostate cancer (reviewed in [16]). The gene discussed is PPARG; the disease is malignant colon neoplasm.